- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech High Insider Buying
Canadian Pharmaceuticals & Biotech High Insider Buying
Results
24
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
24 companies
Knight Therapeutics
Market Cap: CA$575.3m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.80
7D
-0.7%
1Y
6.2%
Eupraxia Pharmaceuticals
Market Cap: CA$569.8m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$11.25
7D
-4.6%
1Y
156.3%
NervGen Pharma
Market Cap: CA$433.3m
A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
NGEN
CA$5.44
7D
-16.6%
1Y
85.7%
Organigram Global
Market Cap: CA$274.1m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$2.03
7D
-7.3%
1Y
-3.3%
Grown Rogue International
Market Cap: CA$140.0m
A craft cannabis company, focuses on premium flower and flower-derived products.
GRIN
CA$0.56
7D
0%
1Y
-37.8%
Medexus Pharmaceuticals
Market Cap: CA$91.9m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.83
7D
-3.4%
1Y
-25.5%
Medicenna Therapeutics
Market Cap: CA$73.4m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.88
7D
-2.2%
1Y
-30.7%
Sharp Therapeutics
Market Cap: CA$72.2m
A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.
SHRX
CA$2.40
7D
0%
1Y
n/a
LIR Life Sciences
Market Cap: CA$56.6m
Operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders.
SKNY
CA$2.03
7D
-2.9%
1Y
n/a
Sona Nanotech
Market Cap: CA$45.8m
Operates as a nanotechnology life sciences company.
SONA
CA$0.40
7D
-10.1%
1Y
50.9%
Rubicon Organics
Market Cap: CA$30.2m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
1.1%
1Y
28.6%
Microbix Biosystems
Market Cap: CA$29.8m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.21
7D
0%
1Y
-53.8%
Optimi Health
Market Cap: CA$29.4m
Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.
OPTI
CA$0.30
7D
-6.2%
1Y
48.8%
Simply Solventless Concentrates
Market Cap: CA$20.8m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.18
7D
-2.7%
1Y
-74.3%
Hemostemix
Market Cap: CA$18.5m
A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.
HEM
CA$0.095
7D
0%
1Y
-67.2%
Cytophage Technologies
Market Cap: CA$10.5m
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO
CA$0.15
7D
-3.1%
1Y
-35.4%
Glow Lifetech
Market Cap: CA$10.0m
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.
GLOW
CA$0.055
7D
10.0%
1Y
-21.4%
Blueberries Medical
Market Cap: CA$9.9m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.02
7D
33.3%
1Y
33.3%
Christina Lake Cannabis
Market Cap: CA$8.7m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.035
7D
0%
1Y
0%
BioVaxys Technology
Market Cap: CA$7.9m
A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.
BIOV
CA$0.18
7D
-18.2%
1Y
-67.3%
Marvel Biosciences
Market Cap: CA$7.8m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.14
7D
-3.6%
1Y
-12.9%
Kane Biotech
Market Cap: CA$7.3m
A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.
KNE
CA$0.04
7D
0%
1Y
-61.9%
City View Green Holdings
Market Cap: CA$2.7m
A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.
CVGR
CA$0.055
7D
-8.3%
1Y
-63.3%
Algernon Health
Market Cap: CA$2.4m
Operates as a clinical stage pharmaceutical development company in Canada and Australia.
AGN
CA$0.05
7D
0%
1Y
-37.5%